1. Home
  2. ATO vs RMD Comparison

ATO vs RMD Comparison

Compare ATO & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atmos Energy Corporation

ATO

Atmos Energy Corporation

HOLD

Current Price

$181.17

Market Cap

29.9B

Sector

Utilities

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$226.41

Market Cap

33.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATO
RMD
Founded
1906
1989
Country
United States
United States
Employees
N/A
10600
Industry
Oil/Gas Transmission
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9B
33.2B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
ATO
RMD
Price
$181.17
$226.41
Analyst Decision
Hold
Buy
Analyst Count
9
10
Target Price
$173.63
$293.70
AVG Volume (30 Days)
902.8K
843.4K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
2.16%
1.05%
EPS Growth
9.22
N/A
EPS
2.44
N/A
Revenue
$4,702,755,000.00
N/A
Revenue This Year
$15.74
$10.64
Revenue Next Year
$11.26
$7.38
P/E Ratio
$75.85
$25.61
Revenue Growth
12.91
N/A
52 Week Low
$141.59
$199.92
52 Week High
$190.13
$293.81

Technical Indicators

Market Signals
Indicator
ATO
RMD
Relative Strength Index (RSI) 46.00 28.86
Support Level $163.67 N/A
Resistance Level $187.98 $260.21
Average True Range (ATR) 3.03 4.93
MACD -0.87 -2.38
Stochastic Oscillator 7.58 4.61

Price Performance

Historical Comparison
ATO
RMD

About ATO Atmos Energy Corporation

Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3.3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: